Franklin Health Research Center
Franklin, Tennessee, 37067, United States
NCT Number: NCT04980573
The purpose of this study is to assess the efficacy of plant based aromas on energy levels among otherwise healthy female survivors of COVID-19.
Looking for future studies?
Notify Me19 year–49 year
All sexes
Interventional
Not applicable
Franklin, Tennessee, 37067, United States
After being informed about the study, participants will provide informed consent, then will be randomized into one of two groups in a 1:1 ratio. Participants will either inhale an inert blend twice a day or an active aroma twice a day for 14 days.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The aromatherapy intervention consists of inhaling a fragrant oil extracted from citrus peels, plant resins, and leaves.
The placebo intervention consists of inhaling an oil extracted from inert plant matter.
Time frame: Baseline and Day 14
The MFSI is a validated, 83 question scale measuring fatigue levels across ten domains. Each question is scored from 0-5 on a Likert scale, with higher scores indicating higher levels of fatigue.
Time frame: Baseline and Day 14
This survey includes 9 questions regarding levels of depression. Each question is scored from 0-3 on a Likert scale, with higher scores indicating higher levels of depression.
Nutraceuticals Research Institute
Other
The Effects of Aromatherapy on Post COVID-19 Fatigue: A Randomized, Double Blind, Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04806815
COVID-19, Coronaviridae Infections
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT04860869
COVID-19, Cognition Disorders
Galveston, Texas, United States
View Trial DetailsNCT05027724
Autonomic Nervous System Diseases, COVID-19
Dublin, Co. Dublin, Ireland
View Trial DetailsNCT04795557
Anxiety Disorders, Behavior
Tbilisi, Georgia
View Trial Details